Medical speaks to Dr. Nicole Lieberman about her latest research that discovered delayed immune responses may affect COVID-19 mortality rates.

Offering a comprehensive portfolio of SARS-CoV-2 molecular QC standards, Microbiologics is launching IVD Process Controls and Inactivated Whole Vir

Meng Yan just published a scientific paper summarizing how the unusual features of the SARS-CoV-2 genome suggest … sophisticated laboratory modific

The Pew Charitable Trusts announced today the six pairs of researchers who will make up its 2020 class of Innovation Fund investigators.

As the COVID-19 pandemic continues, nucleic acid vaccines are among the many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine c

Host Ben Kieffer is joined by Buena Vista University interim President Brian Lenzmeier to talk about how his campus has been navigating the pandemi

I checked in with three people whose work has touched on all aspects of the novel coronavirus, from the nuances of how it spreads to its emotional

India has come a long way from conducting just one test at the lab in the National Institute of Virology, Pune in January to 5,06,50,128 as on date

The Breakthrough Prize Foundation today announced the top 30 student semifinalists in the sixth annual Breakthrough Junior Challenge global science

New research by the Cyprus Institute of Neurology and Genetics aims to provide insight into the coronavirus outbreak and particularly the degree of

How Spain pulls itself out of the coronavirus second wave may be a blueprint for other nations and cities to follow.

Ellen Kuwana, a science communicator in Seattle, read about the scientists working overtime to process COVID-19 tests at the University of Washingt

Hendrik Streeck said people developing herd immunity against the virus sounded "terrible" but this is required in terms of slowing down t

Ellen Kuwana, a science communicator in Seattle, read about the scientists working overtime to process COVID-19 tests at the University of Washingt

The fifth annual AGBT Precision Health conference, September 10-11, 2020, will feature 15+ expert speakers to present updates on their latest resea

When someone gets a COVID-19 test, the result does one thing: tells that person if they have the coronavirus in their body.

Most people with COVID-19 have relatively mild disease, but a subset of people develop severe pneumonia and respiratory failure, potentially leadin

Most people with COVID-19 have relatively mild disease, but a subset of people develop severe pneumonia and respiratory failure, potentially leadin

(NYSE American: NNVC) (the “Company”) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines pla

Los Angeles, California, // KISSPR // New Book by Vijay Jojo Chokal-Ingam - Coronavirus COVID-19 - Obama and Biden Are Responsible .

The team from Marien Hospital and the department of Virology of Ruhr-Universität Bochum (RUB) as well as the Clinic for Infectious Diseases, the Cl

WebMD Chief Medical Officer John Whyte talks with virologist Dr Alexander Greninger about whether coronavirus antibodies can protect people from CO

But they are skeptical about this vaccine," said Stephenson, director of the clinical trials unit at the Center for Virology and Vaccine Resea

The news of a Russian vaccine being registered before going into stage 3 of testing drew much criticism.